Patient portal

NKKR supports data-driven improvements in care

6 juli 2026

The Netherlands Childhood Cancer Registry (NKKR) has been recognized as a quality registry by the Dutch National Health Care Institute (Zorginstituut Nederland). This recognition formally acknowledges the NKKR as a tool for data-driven care evaluation. It lays a crucial foundation for further improvements in care of children with cancer.

Each year, approximately 600 children in the Netherlands are diagnosed with cancer. The Princess Máxima Center for pediatric oncology treats all these children. During and after treatment, information is collected about the disease, treatment, and outcomes. The Netherlands Childhood Cancer Registry brings these data together in a single national registry, including historical diagnoses dating back to 1963.

This creates a comprehensive overview of treatment outcomes and long-term effects. The NKKR focuses not only on survival, but also on how children are doing later in life. In this way, the registry provides a strong foundation for learning from childhood cancer care in a structured and data-driven manner.

Dr. Wouter Kollen, pediatric oncologist and Director of Medical Care at the Máxima Center, says: ‘The NKKR provides healthcare professionals with important information about childhood cancer and its short- and long-term consequences. This enables us to monitor and continuously improve both survival and quality of life.’

What does this mean for children and parents?

For the first time, the NKKR brings together data at the tumor-specific level and links these to internationally recognized outcome indicators. This enables healthcare professionals to better compare treatment outcomes, learn from previous treatments, and further improve care. The NKKR looks not only at treatment results, but also at outcomes that matter to children and survivors.

Mildred Klarenbeek is director of the Dutch Childhood Cancer Organization (VKKN) and steering group member representing the patient perspective. She says: ‘Through the NKKR, children and parents will gain access to reliable information about treatment outcomes. This creates greater transparency and helps families and their pediatric oncologist make better-informed decisions together. Especially during an uncertain period, this information can provide reassurance and confidence.’

A foundation for the future

The NKKR makes treatment outcomes more visible and comparable. These insights help care teams evaluate results and identify opportunities for improvement. In this way, the NKKR contributes to the mission of the Princess Máxima Center: to cure every child with cancer, with optimal quality of life.

International foundation for data-driven quality improvement

With its recognition as a quality registry, the NKKR gains a formal position within the Dutch healthcare quality system. For the Princess Maxima Center, this recognition contributes to a national and international infrastructure for data-driven learning in pediatric oncology and provides a structural foundation for quality improvement, benchmarking, and research.

By being included in the Dutch Healthcare Institute’s registry of quality registries, it meets the requirements of the Healthcare Quality Registries Act (part of Wkkgz), which took effect on January 1, 2026. This new legislation not only provides for funding from Zorgverzekeraars Nederland but also establishes clear frameworks for data submission and provides a legal basis for data processing. 

Making outcomes visible and accessible

The NKKR brings together data on diagnosis, treatment and outcomes at the tumor-specific level and links them to internationally validated outcomes. In addition, dashboards make outcomes visible and accessible. These support care teams in monitoring results, identifying variation in outcomes, and recognizing opportunities for improvement.

In the coming years, the focus will be on further improving data quality, expanding benchmarking, and applying NKKR data in clinical practice, including within the LATER clinic.

Pediatric oncologist and Program Lead Quality of Life Annelies Mavinkurve-Groothuis: ‘By collecting outcomes that matter to patients and survivors, the NKKR has the potential to provide a reliable foundation for personalized follow-up care and shared decision-making.’